Minimal adverse influence of maternal hepatitis B carrier status on perinatal outcomes and child’s growth

Abstract

Maternal HBsAg carrier status does not add risk for adverse neonatal outcomes or child's growth; therefore, heightening surveillance for adverse neonatal complications in HBV-infected pregnant women may be unnecessary.